Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_235_библиотеки_им_акад_М_И_Перельмана
.pdf
171
139. Gender differences in presentation, coronary intervention, and outcomes of
28,985 acute coronary syndrome patients in Victoria, Australia / L. Worrall-Carter, S.
McEvedy, A. Wilson, M. A. Rahman // Women's health issues. – 2016. – Vol. 26, № 1.
– P. 14–20.
140. Global and regional diabetes prevalence estimates for 2019 and projections
for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9
th
edition / P. Saeedi, I. Petersohn, P. Salpea [et al.] // Diabetes research and clinical practice.
– 2019. – Vol. 157, Article 107843.
141. Glucocorticoid treatment in patients with newly diagnosed immune
thrombocytopenia switches CD14(
++
) CD16(
+
) intermediate monocytes from a pro-
inflammatory to an anti-inflammatory phenotype / E. L. Williams, M. L. Stimpson, P. J.
P. Lait [et al.] // British journal of haematology. – 2021. – Vol. 192, № 2. – P. 375–384.
142. Grant, P. J. The 2019 ESC Guidelines on diabetes, pre-diabetes, and
cardiovascular diseases developed in collaboration with the EASD / P. J. Grant, F.
Cosentino // European heart journal. – 2019. – Vol. 40, № 39. – P. 3215–3217.
143. Groarke, E. M. Aging and hematopoiesis / E. M. Groarke, N. S. Young //
Clinics in geriatric medicine. – 2019. – Vol. 35, № 3. – P. 285–293.
144. High cardiovascular risk of patients with type 2 diabetes is only partially
attributed to angiographic burden of atherosclerosis / S. Battermann, A. Milzi, R. Dettori
[et al.] // Diabetes and vascular disease research. – 2020. – Vol. 17, № 9. – Article
1479164120953612.
145. Home, P. Controversies for glucose control targets in type 2 diabetes:
exposing the common ground / P. Home // Diabetes care. – 2019. – Vol. 42, № 9. – P.
1615–1623.
146. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and
projections for 2045 / N. H. Cho, J. E. Shaw, S. Karuranga [et al.] // Diabetes research
and clinical practice. – 2018. – Vol. 138. – P. 271–281.
147. Ilatovskaya, D. V. Adaptive immunity-driven inflammation and
cardiovascular disease / D. V. Ilatovskaya, G. V. Halade, K. Y. DeLeon-Pennell //
https://t.me/med1917
172
American journal of physiology. Heart and circulatory physiology. – 2019. – Vol. 317,
№ 6. – P. H1254–H1257.
148. Immune cell repertoire and their mediators in patients with acute myocardial
infarction or stable angina pectoris / W. Yan, Y. Song, L. Zhou [et al.] // International
journal of medical sciences. – 2017. – Vol. 14, № 2. – P. 181–190.
149. Immune cells as targets for cardioprotection: new players and novel
therapeutic opportunities / I. Andreadou, H. A. Cabrera-Fuentes, Y. Devaux [et al.] //
Cardiovascular research. – 2019. – Vol. 115, № 7. – P. 1117–1130.
150. Immunobiology of atherosclerosis: a complex net of interactions / B.
Herrero-Fernandez, R. Gomez-Bris, B. Somovilla-Crespo, J. M. Gonzalez-Granado //
International journal of molecular sciences. – 2019. – Vol. 20, № 21. – Article 5293.
151. Impact of CD14(
++
)CD16
(+
) monocytes on coronary plaque vulnerability
assessed by optical coherence tomography in coronary artery disease patients / H.
Yamamoto, N. Yoshida, T. Shinke [et al.] // Atherosclerosis. – 2018. – Vol. 269. – P.
245–251.
152. Impact of heterogeneity of human peripheral blood monocyte subsets on
myocardial salvage in patients with primary acute myocardial infarction / H. Tsujioka, T.
Imanishi, H. Ikejima [et al.] // Journal of the American College of Cardiology. – 2009. –
Vol. 54, № 2. – P. 130–138.
153. Impact of type II diabetes and gender on major clinical events after
percutaneous coronary intervention / M. Sayadi, M. J. Zibaeenezhad, K. Safaei [et al.] //
Primary care diabetes. – 2021. – Vol. 15, № 2. – P. 347–351.
154. Incidence and risk factors for recurrent cardiovascular disease in middle-
eastern adults: a retrospective study / R. D. Govender, S. Al-Shamsi, E. S. Soteriades, D.
Regmi // BMC cardiovascular disorders. – 2019. – Vol. 19, № 1. – Article 253.
155. Incidence, timing, predictors and impact of acute heart failure complicating
ST-segment elevation myocardial infarction in patients treated by primary percutaneous
coronary intervention / V. Auffret, G. Leurent, M. Gilard [et al.] // International journal
of cardiology. – 2016. – Vol. 221. – P. 433–442.
https://t.me/med1917
173
156. Induction of a monocyte/macrophage phenotype switch by mesenchymal
stem cells might contribute to improved infarct healing postacute myocardial infarction /
E. N. Ter Horst, B. A. Naaijkens, P. A. Krijnen [et al.] // Minerva cardioangiologica. –
2013. – Vol. 61, № 6. – P. 617–625.
157. Inflammation following acute myocardial infarction: Multiple players,
dynamic roles, and novel therapeutic opportunities / S. B. Ong, S. Hernández-Reséndiz,
G. E. Crespo-Avilan [et al.] // Pharmacology and therapeutics. – 2018. – Vol. 186. – P.
73–87.
158. Inflammation in renal diseases: new and old players / V. Andrade-Oliveira,
O. Foresto-Neto, I. K. M. Watanabe [et al.] // Frontiers in pharmacology. – 2019. – Vol.
10, Article 1192.
159. Inflammation in ST-elevation myocardial infarction: risk factors, patterns of
presentation and association with clinical picture and outcome, an observational study
conducted at the Institute of Cardiology-National Hospital of Sri Lanka / M. R. Navinan,
S. Mendis, S. Wickramasinghe [et al.] // BMC cardiovascular disorders. – 2019. – Vol.
19, № 1. – Article 111.
160. Inflammatory markers in ST-elevation acute myocardial infarction / I. M.
Seropian, C. Sonnino, B. W. Van Tassell [et al.] // European heart journal. Acute
cardiovascular care. – 2016. – Vol. 5, № 4. – P. 382–395.
161. In-hospital peak glycemia in predicting no-reflow phenomenon in diabetic
patients with STEMI treated with primary percutaneous coronary intervention / F. Liu, R.
Huang, Y. Li [et al.] // Journal of diabetes research. – 2021. – Vol. 2021, Article 6683937.
162. Innate immunity as a target for acute cardioprotection / C. J. Zuurbier, A.
Abbate, H. A. Cabrera-Fuentes [et al.] // Cardiovascular research. – 2019. – Vol. 115, №
7. – P. 1131–1142.
163. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular
disease / A. Abbate, S. Toldo, C. Marchetti [et al.] // Circulation research. – 2020. – Vol.
126, № 9. – P. 1260–1280.
https://t.me/med1917
174
164. Intermediate and nonclassical monocytes show heterogeneity in patients
with different types of acute coronary syndrome / M. P. G. Leers, C. Stockem, D.
Ackermans [et al.] // Cytometry. Part A. – 2017. – Vol. 91, № 11. – P. 1059–1067.
165. Intermediate monocytes lead to enhanced myocardial remodelling in STEMI
patients with diabetes / W. Lu, Z. Zhang, C. Fu, G. Ma // International heart journal. –
2015. – Vol. 56, № 1. – P. 22–28.
166. Invasive treatment of NSTEMI patients in German Chest Pain Units –
Evidence for a treatment paradox / F. P. Schmidt, C. Schmitt, M. Hochadel [et al.] //
International journal of cardiology. – 2018. – Vol. 255. – P. 15–19.
167. Kain, V. Role of neutrophils in ischemic heart failure / V. Kain, G. V. Halade
// Pharmacology and therapeutics. – 2020. – Vol. 205, Article 107424.
168. Kinetics of neutrophil subsets in acute, subacute, and chronic inflammation
/ S. H. Bongers, N. Chen, E. van Grinsven [et al.] // Frontiers in immunology. – 2021. –
Vol. 12, Article 674079.
169. Kratofil, R. M. Monocyte conversion during inflammation and injury / R. M.
Kratofil, P. Kubes, J. F. Deniset // Arteriosclerosis, thrombosis, and vascular biology. –
2017. – Vol. 37, № 1. – P. 35–42.
170. Lafuse, W. P. Role of cardiac macrophages on cardiac inflammation, fibrosis
and tissue repair / W. P. Lafuse, D. J. Wozniak, M. V. S. Rajaram // Cells. – 2020. – Vol.
10, № 1. – Article 51.
171. Leukocyte-expressed β
2
-adrenergic receptors are essential for survival after
acute myocardial injury / L. A. Grisanti, A. M. Gumpert, C. J. Traynham [et al.] //
Circulation. – 2016. – Vol. 134, № 2. – P. 153–167.
172. Levey, A. S. GFR estimation: from physiology to public health / A. S. Levey,
L. A. Inker, J. Coresh // American journal of kidney diseases. – 2014. – Vol. 63, № 5. –
P. 820–834.
173. Libby, P. Inflammation in atherosclerosis-no longer a theory / P. Libby //
Clinical chemistry. – 2021. – Vol. 67, № 1. – P. 131–142.
174. Lower Apo A-I and lower HDL-C levels are associated with higher
intermediate CD14
++
CD16
+
monocyte counts that predict cardiovascular events in
https://t.me/med1917
175
chronic kidney disease / K. S. Rogacev, A. M. Zawada, I. Emrich [et al.] //
Arteriosclerosis, thrombosis, and vascular biology. – 2014. – Vol. 34, № 9. – P. 2120–
2127.
175. Lower HDL-C levels are associated with higher expressions of CD16 on
monocyte subsets in coronary atherosclerosis / Y. Xiang, B. Liang, X. Zhang, F. Zheng
// International journal of medical sciences. – 2020. – Vol. 17, № 14. – P. 2171–2179.
176. Lymphocyte and monocyte flow cytometry immunophenotyping as a
diagnostic tool in uncharacteristic inflammatory disorders / H. Janols, A. Bredberg, I.
Thuvesson [et al.] // BMC infectious diseases. – 2010. – Vol. 10, Article 205.
177. Ma, Y. Cardiac macrophage biology in the steady-state heart, the aging heart,
and following myocardial infarction / Y. Ma, A. J. Mouton, M. L. Lindsey // Translational
research. – 2018. – Vol. 191. – P. 15–28.
178. Mandal, A. Natural killer cells: In health and disease / A. Mandal, C.
Viswanathan // Hematology/oncology and stem cell therapy. – 2015. – Vol. 8, № 2. – P.
47–55.
179. Mon2 predicts poor outcome in ST-elevation myocardial infarction / E.
Shantsila, A. Ghattas, H. R. Griffiths, G. Y. H. Lip // Journal of internal medicine. – 2019.
– Vol. 285, № 3. – P. 301–316.
180. Monocyte heterogeneity in myocardial infarction with and without ST
elevation and its association with angiographic findings / U. Arslan, I. Kocaoğlu, M. M.
Balci [et al.] // Coronary artery disease. – 2013. – Vol. 24, № 5. – P. 404–411.
181. Monocyte subset accumulation in the human heart following acute
myocardial infarction and the role of the spleen as monocyte reservoir / A. M. van der
Laan, E. N. Ter Horst, R. Delewi [et al.] // European heart journal. – 2014. – Vol. 35, №
6. – P. 376–385.
182. Monocyte subsets are differently associated with infarct size, left ventricular
function, and the formation of a potentially arrhythmogenic scar in patients with acute
myocardial infarction / X. Bosch, B. Jáuregui, N. Villamor [et al.] // Journal of
cardiovascular translational research. – 2020. – Vol. 13, № 5. – P. 722–730.
https://t.me/med1917
176
183. Monocyte subsets in myocardial infarction: A review / J. Arfvidsson, F.
Ahlin, K. G. Vargas [et al.] // International journal of cardiology. – 2017. – Vol. 231. –
P. 47–53.
184. Monocyte subsets predict mortality after cardiac arrest / K. A. Krychtiuk, M.
Lenz, B. Richter [et al.] // Journal of leukocyte biology. – 2021. – Vol. 109, № 6. – P.
1139–1146.
185. Monocyte/lymphocyte ratio is related to the severity of coronary artery
disease and clinical outcome in patients with non-ST-elevation myocardial infarction / H.
Chen, M. Li, L. Liu [et al.] // Medicine. – 2019. – Vol. 98, № 26. – Article e16267.
186. Monocyte/lymphocyte ratio predicts the severity of coronary artery disease:
a syntax score assessment / H. Ji, Y. Li, Z. Fan [et al.] // BMC cardiovascular disorders.
– 2017. – Vol. 17, № 1. – Article 90.
187. Monocytes in coronary artery disease and atherosclerosis: where are we
now? / A. Ghattas, H. R. Griffiths, A. Devitt [et al.] // Journal of the American College
of Cardiology. – 2013. – Vol. 62, № 17. – P. 1541–1551.
188. Monocytes, macrophages, and metabolic disease in atherosclerosis / M. C.
Flynn, G. Pernes, M. K. S. Lee [et al.] // Frontiers in pharmacology. – 2019. – Vol. 10,
Article 666.
189. Multimorbidity and survival for patients with acute myocardial infarction in
England and Wales: Latent class analysis of a nationwide population-based cohort / M.
Hall, T. B. Dondo, A. T. Yan [et al.] // PLoS medicine. – 2018. – Vol. 15, № 3. – Article
e1002501.
190. Myocardial contraction fraction, diabetes, and heart failure: The multi-ethnic
study of atherosclerosis / A. G. Bertoni, E. A. Akwo, D. A. Bleumke [et al.] // Circulation.
– 2012. – Vol. 125, Article AP243.
191. Nahrendorf, M. Monocyte and macrophage heterogeneity in the heart / M.
Nahrendorf, F. K. Swirski // Circulation research. – 2013. – Vol. 112, № 12. – P. 1624–
1633.
https://t.me/med1917
177
192. Nature versus number: monocytes in cardiovascular disease / H. Williams,
C. D. Mack, S. C. H. Li [et al.] // International journal of molecular sciences. – 2021. –
Vol. 22, № 17. – Article 9119.
193. Neutrophil heterogeneity and its role in infectious complications after severe
trauma / L. Hesselink, R. Spijkerman, K. J. P. van Wessem [et al.] // World journal of
emergency surgery. – 2019. – Vol. 14, Article 24.
194. Neutrophil signaling during myocardial infarction wound repair / M. J.
Daseke 2nd, U. Chalise, M. Becirovic-Agic [et al.] // Cellular signalling. – 2021. – Vol.
77, Article 109816.
195. Neutrophils orchestrate post-myocardial infarction healing by polarizing
macrophages towards a reparative phenotype / M. Horckmans, L. Ring, J. Duchene [et
al.] // European heart journal. – 2017. – Vol. 38, № 3. – P. 187–197.
196. Non-classical monocytes display inflammatory features: Validation in
Sepsis and Systemic Lupus Erythematous / R. Mukherjee, P. K. Barman, P. K. Thatoi [et
al.] // Scientific reports. – 2015. – Vol. 5, Article 13886.
197. Nonclassical monocytes in health and disease / P. B. Narasimhan, P.
Marcovecchio, A. A. J. Hamers, C. C. Hedrick // Annual review of immunology. – 2019.
– Vol. 37. – P. 439–456.
198. Norhammar, A. Long-term mortality after PCI in patients with diabetes
mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry / A.
Norhammar, B. Lagerqvist, N. Saleh // EuroIntervention. – 2010. – Vol. 5, № 8. – P. 891–
897.
199. Novel subgroups of adult-onset diabetes and their association with
outcomes: a data-driven cluster analysis of six variables / E. Ahlqvist, P. Storm, A.
Käräjämäki [et al.] // The lancet. Diabetes and endocrinology. – 2018. – Vol. 6, № 5. – P.
361–369.
200. Obesity: preventing and managing the global epidemic. Report of a WHO
consultation // World Health Organization technical report series. – 2000. – Vol. 894. –
P. I-XII, 1–253.
https://t.me/med1917
178
201. Okeke, E. B. The pivotal role of regulatory T cells in the regulation of innate
immune cells / E. B. Okeke, J. E. Uzonna // Frontiers in immunology. – 2019. – Vol. 10,
Article 680.
202. Pharmacological blockage of ICAM-1 improves angiotensin II-induced
cardiac remodeling by inhibiting adhesion of LFA-1
+
monocytes / Q.-Y. Lin, P.-P. Lang,
Y.-L. Zhang [et al.] // American journal of physiology. Heart and circulatory physiology.
– 2019. – Vol. 317, № 6. – P. H1301–H1311.
203. Phillips, J. H. Platelet-induced expression of Fc gamma RIII (CD16) on
human monocytes / J. H. Phillips, C. W. Chang, L. L. Lanier // European journal of
immunology. – 1991. – Vol. 21, № 4. – P. 895–899.
204. Post-reperfusion enhancement of CD14(
+
)CD16(
-
) monocytes and
microvascular obstruction in ST-segment elevation acute myocardial infarction / H.
Tsujioka, T. Imanishi, H. Ikejima [et al.] // Circulation journal. – 2010. – Vol. 74, № 6. –
P. 1175–1182.
205. Potential role of invariant natural killer T cells in outcomes of acute
myocardial infarction / J. Novak, J. Dobrovolny, P. Tousek [et al.] // International journal
of cardiology. – 2015. – Vol. 187. – P. 663–665.
206. Prabhu, S. D. The biological basis for cardiac repair after myocardial
infarction: from inflammation to fibrosis / S. D. Prabhu, N. G. Frangogiannis //
Circulation research. – 2016. – Vol. 119, № 1. – P. 91–112.
207. Predictive value of admission red cell distribution width-platelet ratio for no-
reflow phenomenon in acute ST segment elevation myocardial infarction undergoing
primary percutaneous coronary intervention / T. Celik, S. Balta, M. Demir [et al.] //
Cardiology journal. – 2016. – Vol. 23, № 1. – P. 84–92.
208. Predictive value of neutrophil to lymphocyte ratio on long-term outcomes of
acute myocardial infarction patients with multivessel disease / N. Xu, X. F. Tang, J. J. Xu
[et al.] // Zhonghua xin xue guan bing za zhi. – 2019. – Vol. 47, № 1. – P. 42–48.
209. Predictive value of random blood glucose versus fasting blood glucose on
in-hospital adverse events in patients with ST-segment elevation acute myocardial
https://t.me/med1917
179
infarction / Y. Qin, G. Yan, Y. Qiao [et al.] // BMC cardiovascular disorders. – 2020. –
Vol. 20, № 1. – Article 95.
210. Predictors of high Killip class after ST segment elevation myocardial
infarction in the era of primary reperfusion / L. Vicent, J. Velásquez-Rodríguez, M. J.
Valero-Masa [et al.] // International journal of cardiology. – 2017. – Vol. 248. – P. 46–
50.
211. Primary prevention efforts are poorly developed in people at high
cardiovascular risk: A report from the European Society of Cardiology
EURObservational Research Programme EUROASPIRE V survey in 16 European
countries / K. Kotseva, G. De Backer, D. De Bacquer [et al.] // European journal of
preventive cardiology. – 2021. – Vol. 28, № 4. – P. 370–379.
212. Prognostic impact of multimorbidity in patients with type 2 diabetes and ST-
elevation myocardial infarction / B. Hudzik, I. Korzonek-Szlacheta, J. Szkodziński [et
al.] // Oncotarget. – 2017. – Vol. 8, № 61. – P. 104467–104477.
213. Prognostic value of fasting glucose on the risk of heart failure and left
ventricular systolic dysfunction in non-diabetic patients with ST-segment elevation
myocardial infarction / H. Wang, Y. Zhang, Z. Shen [et al.] // Frontiers of medicine. –
2021. – Vol. 15, № 1. – P. 70–78.
214. Prognostic value of neutrophil to lymphocyte ratio for in-hospital mortality
in elderly patients with acute myocardial infarction / T.-M. Guo, B. Ceng, L. Ke [et al.]
// Current medical science. – 2018. – Vol. 38, № 2. – P. 354–359.
215. Randomized trial of Interleukin-6 receptor inhibition in patients with acute
ST-segment elevation myocardial infarction / K. Broch, A. K. Anstensrud, S. Woxholt
[et al.] // Journal of the American College of Cardiology. – 2021. – Vol. 77, № 15. – P.
1845–1855.
216. Reduction in CD16/CD56 and CD16/CD3/CD56 natural killer cells in
coronary artery disease / N. R. Jabir, C. K. Firoz, F. Ahmed [et al.] // Immunological
investigations. – 2017. – Vol. 46, № 5. – P. 526–535.
217. Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction,
insulin resistance, or both in older adults: the Cardiovascular Health Study / F. Imamura,
https://t.me/med1917
180
K. J. Mukamal, J. B. Meigs [et al.] // American journal of epidemiology. – 2013. – Vol.
177, № 12. – P. 1418–1429.
218. Risk factors in patients with non-ST segment elevation myocardial infarction
/ D. Mrsic, J. Smajlovic, D. Loncar [et al.] // Materia socio-medica. – 2020. – Vol. 32, №
3. – P. 224–226.
219. Role and analysis of monocyte subsets in cardiovascular disease. Joint
consensus document of the European Society of Cardiology (ESC) Working Groups
"Atherosclerosis & Vascular Biology" and "Thrombosis" / C. Weber, E. Shantsila, M.
Hristov [et al.] // Thrombosis and haemostasis. – 2016. – Vol. 116, № 4. – P. 626–637.
220. Role of B lymphocytes in the infarcted mass in patients with acute
myocardial infarction / A. C. A. Casarotti, D. Teixeira, I. M. Longo-Maugeri [et al.] //
Bioscience reports. – 2021. – Vol. 41, № 2. – Article BSR20203413.
221. Role of inflammatory markers in elderly type 2 diabetic patients with mild
cognitive impairment / S. S. Hosny, A. M. Bahaaeldin, M. S. Khater [et al.] // Current
diabetes reviews. – 2019. – Vol. 15, № 3. – P. 247–253.
222. Ross, R. Atherosclerosis – an inflammatory disease / R. Ross // The New
England journal of medicine. – 1999. – Vol. 340, № 2. – P. 115–126.
223. Ruggieri, G. Analysis of past and present methods of measuring and
estimating body surface area and the resulting evaluation of its doubtful suitability to
universal application / G. Ruggieri, A. R. Rocca // Blood purification. – 2010. – Vol. 30,
№ 4. – P. 296–305.
224. Russo, L. Properties and functions of adipose tissue macrophages in obesity
/ L. Russo, C. N. Lumeng // Immunology. – 2018. – Vol. 155, № 4. – P. 407–417.
225. Self-renewing resident cardiac macrophages limit adverse remodeling
following myocardial infarction / S. A. Dick, J. A. Macklin, S. Nejat [et al.] // Nature
immunology. – 2019. – Vol. 20, № 1. – P. 29–39.
226. Source of chronic inflammation in aging / F. Sanada, Y. Taniyama, J.
Muratsu [et al.] // Frontiers in cardiovascular medicine. – 2018. – Vol. 5, Article 12.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана